Good morning, everyone. Welcome to bloomberg surveillance. I am Francine Lacqua here in london. A lot going on, because we have Christine Lagarde testifying in parliament. We will bring you anything that comes out of it. The markets focusing on infections rising around the world. They are focusing around the fact that we could see a stimulus. Lets get to the markets. I dont know if we have them. If we do, it could be great, and it would be a good time to look at them. Overall,ok at stocks they are falling along u. S. Futures, tougher restrictions, progress toward a vaccine. We have plenty more of course on that. Astrazeneca at rising amidst positive news on its coronavirus vaccine. We are hearing from Christine Lagarde. We had an exclusive conversation days ago. The focus is on the need for a stimulus. The focus is also on the need for markets to do a little bit more. She said basically the ecb delivered in the first wave. She is talking about the physical packages, on course for a fis
Worked so much in the first couple of quarters. We are also expecting our investment ipo tomorrow. It is a very, very busy year for us, all in all. You are looking at health care opportunities. Everybody else seems to be doing that. That is why valuations have skyrocketed. What are you finding and what are you concentrating on within that space in particular . Nisa it is interesting. Board. St across the is, is really interesting when we invested in the first company, the first Vaccine Company to list in hong kong. One of our Companies Went out in hong kong, the first device company. Venus, thepo of whole medical device sector has become hot this year. Seen 25 areas we have Companies Getting funded in china alone. I am not sure about the competition. On the discovery side there is also excitement. Because valuation has grown so much, we would still stay away from very expensive deals. Historically, we have been investing 75 at least. Systematically we have been doing the same thing as
France threatens to get out of the rescue plan altogether. 11,000 jobs slashed, the german giant fights for survival. Welcome to the program. Looking at the futures, reflecting the way the european and u. S. Equity markets closed yesterday. Futures down in europe, mixed in the u. S. , reflecting what we saw yesterday were the u. S. Wobbled into the close at the end of the session. New york schools closing seems to be the factor. Breaking news, some commentary from astrazeneca in connection phasehase two, not the three news we have been waiting for. That is expected to come within weeks. This is more detail on the phase two data. They are confirming the vaccines immune response in older adults, that is crucial considering who is most vulnerable to the virus. The lancet is publishing the findings. A lot of stuff we have heard already from phase three trials more advanced than this from other drug companies. It has not been peerreviewed or in journals. We are getting the phase two study,
Whether or not at this point in the economic pandemic cycle they need to spend that bullet. They will be doing some things that are more accommodative. It will be difficult for them to reverse that policy somewhere down the road. Jonathan mike swell of Goldman Sachs is with us. On treasuries, on bad news being bad news, is that your view of things, how high can we take 10year yield . Mike great to be with you, jonathan. On the there is a cap treasury market, and its really the result of looking away from the slow term where there are certain instances where people think about growth postcovid. We see significant vaccine implementation. The jobs report, it will take a long time to get back to normal. The fed will be on hold for the foreseeable future. As a result, you will not see a 50 basis point increase in the 10year. People should sit tight and recognize that rates will stay low for the foreseeable future. Today proves that we will be in this odd situation where markets will look fo
U. N. Secretary. Thank you. Thank you for having us. Were delighted to have you both. So, let me start with you, if i may, doctor. Could you give us a global snapshot of Energy Poverty, where things stand, what populations are affected and what kind of repercussions are for gender equity and employment in the areas of the world that are most affected. Thanks again for having us. I think to just talk about what the Rockefeller Foundation has done and under the leadership of secretary munoz is looking at how we can end this Global Partnership and Energy Poverty. And as you ask, and rightly so, what is the global landscape. Let me start with my own continent. Africa accounts for only 2. 3 of the 270,000 hours of electricity generated. Asia is only 7. 8 . Its africa but also south and central america, its 4. 9 . When you look at those three, africa, 3. 2 , india, 5. 8 , and south and Central Africa america are just 4. 9 , you see theres still large swaths of the global space that is energy